273 related articles for article (PubMed ID: 1000504)
41. Effect of prolactin on growth and the estrogen receptor level of human breast cancer cells (MCF-7).
Shafie S; Brooks SC
Cancer Res; 1977 Mar; 37(3):792-9. PubMed ID: 189915
[TBL] [Abstract][Full Text] [Related]
42. An evaluation of the role of antiestrogen-binding sites in mediating the growth modulatory effects of antiestrogens: studies using t-butylphenoxyethyl diethylamine, a compound lacking affinity for the estrogen receptor.
Sheen YY; Simpson DM; Katzenellenbogen BS
Endocrinology; 1985 Aug; 117(2):561-4. PubMed ID: 4017947
[TBL] [Abstract][Full Text] [Related]
43. A new method for evaluating the inhibitory potency of antiestrogens on breast cancer cell lines.
Madeddu L; Roy F; Leclercq G
Anticancer Res; 1986; 6(1):11-5. PubMed ID: 2420266
[TBL] [Abstract][Full Text] [Related]
44. Quercetin inhibits the growth of a multidrug-resistant estrogen-receptor-negative MCF-7 human breast-cancer cell line expressing type II estrogen-binding sites.
Scambia G; Ranelletti FO; Benedetti Panici P; Piantelli M; Bonanno G; De Vincenzo R; Ferrandina G; Pierelli L; Capelli A; Mancuso S
Cancer Chemother Pharmacol; 1991; 28(4):255-8. PubMed ID: 1879042
[TBL] [Abstract][Full Text] [Related]
45. Effects of estrogens and antiestrogens on androgen-dependent growth of Shionogi carcinoma 115: role of estrogen receptor.
Nohno T; Omukai Y; Watanabe S; Saito T; Senoo T
Cancer Lett; 1982; 15(3):237-44. PubMed ID: 6749283
[TBL] [Abstract][Full Text] [Related]
46. Oestrogen-responsive human breast cancer in long term tissue culture.
Lippman ME; Bolan G
Nature; 1975 Aug; 256(5518):592-3. PubMed ID: 170527
[No Abstract] [Full Text] [Related]
47. Estrogens increase the number of thyrotropin-releasing hormone receptors on mammotropic cells in culture.
Gershengorn MC; Marcus-Samuels BE; Geras E
Endocrinology; 1979 Jul; 105(1):171-6. PubMed ID: 221199
[TBL] [Abstract][Full Text] [Related]
48. Antitumor activity of clomiphene analogs in vitro: relationship to affinity for the estrogen receptor and another high affinity antiestrogen-binding site.
Murphy LC; Sutherland RL
J Clin Endocrinol Metab; 1983 Aug; 57(2):373-9. PubMed ID: 6408114
[TBL] [Abstract][Full Text] [Related]
49. Estrogen and antiestrogen resistance in human breast cancer cell lines.
Bronzert DA; Davidson N; Lippman M
Adv Exp Med Biol; 1986; 196():329-45. PubMed ID: 3521223
[No Abstract] [Full Text] [Related]
50. Regulation of breast tumor growth by high dose estrogen is independent of the presence of estrogen receptors.
Hug V; Drewinko B; Hortobagyi GN; Blumenschein G
Breast Cancer Res Treat; 1985; 6(3):237-40. PubMed ID: 4092099
[TBL] [Abstract][Full Text] [Related]
51. Nonsteroidal antiestrogens are estrogen-receptor-targeted growth inhibitors that can act in the absence of estrogens.
Rochefort H
Horm Res; 1987; 28(2-4):196-201. PubMed ID: 3331372
[TBL] [Abstract][Full Text] [Related]
52. Characterization of MCF 7 breast cancer cell growth inhibition by the antiestrogen nitromifene (CI 628) and selected metabolites.
Ruenitz PC; Thompson CB; Srivatsan V
J Steroid Biochem; 1989 Sep; 33(3):365-9. PubMed ID: 2550704
[TBL] [Abstract][Full Text] [Related]
53. Estrogens and antiestrogens stimulate release of bone resorbing activity by cultured human breast cancer cells.
Valentin-Opran A; Eilon G; Saez S; Mundy GR
J Clin Invest; 1985 Feb; 75(2):726-31. PubMed ID: 3855865
[TBL] [Abstract][Full Text] [Related]
54. The antiproliferative effect of tamoxifen in breast cancer cells: mediation by the estrogen receptor.
Bardon S; Vignon F; Derocq D; Rochefort H
Mol Cell Endocrinol; 1984 May; 35(2-3):89-96. PubMed ID: 6734930
[TBL] [Abstract][Full Text] [Related]
55. Phenol red in tissue culture media is a weak estrogen: implications concerning the study of estrogen-responsive cells in culture.
Berthois Y; Katzenellenbogen JA; Katzenellenbogen BS
Proc Natl Acad Sci U S A; 1986 Apr; 83(8):2496-500. PubMed ID: 3458212
[TBL] [Abstract][Full Text] [Related]
56. Estrogen responsive creatine kinase in human breast cancer cells.
Scambia G; Natoli V; Panici PB; Sica G; Mancuso S
J Cancer Res Clin Oncol; 1986; 112(1):29-32. PubMed ID: 3733865
[TBL] [Abstract][Full Text] [Related]
57. Estrogen stimulates cell proliferation and the increase of a 52,000 dalton glycoprotein in human breast cancer cells.
Iacobelli S; Scambia G; Natoli V; Natoli C; Sica G
J Steroid Biochem; 1984 Mar; 20(3):747-52. PubMed ID: 6708549
[TBL] [Abstract][Full Text] [Related]
58. In vitro analysis of the cellular proliferative response to 17-beta-estradiol of human breast cancer.
Podhajcer OL; Bravo AI; Dain L; Guman N; Bover L; Mordoh J
Cancer; 1988 May; 61(9):1807-12. PubMed ID: 3281743
[TBL] [Abstract][Full Text] [Related]
59. Short-term tissue culture of human breast cancer: presence of estrogen receptors and 17 beta-estradiol stimulation of RNA synthesis.
Sanfilippo O; Daidone MG; Di Fronzo G; Silvestrini R
Cancer; 1979 Jun; 43(6):2365-9. PubMed ID: 455226
[TBL] [Abstract][Full Text] [Related]
60. Molecular conformation, receptor binding, and hormone action of natural and synthetic estrogens and antiestrogens.
Duax WL; Griffin JF; Weeks CM; Korach KS
Environ Health Perspect; 1985 Sep; 61():111-21. PubMed ID: 3905370
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
